Scientists compare immune responses to viral and bacterial infections in ICU patients

NCT ID NCT05671159

Ongoing Knowledge-focused Sponsor: University Hospital, Limoges Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how the immune system of patients in the intensive care unit (ICU) responds to severe infections caused by viruses or bacteria. Researchers will take extra blood samples from 38 adults to analyze immature granulocytes, a type of immune cell. The goal is to see if these cells behave differently depending on whether the infection is viral or bacterial, which could improve understanding of immune impairment in critical illness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better understand how the immune system responds differently to viral and bacterial infections in critically ill patients.
What could go wrong: This is a small, observational study with only 38 participants, so findings may not apply to all patients. It is not testing a treatment, so no direct benefit to participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis viral infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEPSIS VIRAL INFECTION

Contacts and locations

Locations

Limoges University Hospital

Limoges, 87042, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.